News Release

CDC interventions targeting diabetes in pregnancy could improve maternal and infant health

Peer-Reviewed Publication

Mary Ann Liebert, Inc./Genetic Engineering News

<em>Journal of Women's Health</em>

image: Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. view more 

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, May 28, 2018--Diabetes in pregnant women can have serious health consequences for both mother and baby, and the U.S. Centers for Disease Control and Prevention (CDC) has identified four target areas in which increased surveillance, screening, and preventive care can improve maternal and infant health. CDC researchers provide an up-to-date review of the science related to diabetes during pregnancy and describe the activities they have implemented at different stages of pregnancy, from preconception to postpartum care, in an article published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website.

Coauthors Shin Kim, MPH, Nicholas Deputy, PhD, MPH, and Cheryl Robbins, PhD, MS, Centers for Disease Control and Prevention, Atlanta, GA discuss the risks associated with preexisting and gestational diabetes and highlight four main preventive activities in the article entitled "Diabetes During Pregnancy: Surveillance, Preconception Care, and Postpartum Care." These include improved surveillance of pregnant women for diabetes, preconception care for women with preexisting diabetes, postpartum screening for women with gestational diabetes, and programs designed to prevent the progression of gestational diabetes to type 2 diabetes post-pregnancy.

"A greater awareness of the risks of diabetes during and after pregnancy and more widespread efforts to identify pregnant women with preexisting or gestational diabetes may help mitigate some of the risks, particularly through improved glucose control and the opportunity to introduce screening and lifestyle interventions as part of postpartum care," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.

###

About the Journal

Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. Led by Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health, the Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website. Journal of Women's Health is the official journal of the Academy of Women's Health and the Society for Women's Health Research.

About the Academy

Academy of Women's Health is an interdisciplinary, international association of physicians, nurses, and other health professionals who work across the broad field of women's health, providing its members with up-to-date advances and options in clinical care that will enable the best outcomes for their women patients. The Academy's focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment of women across the lifespan.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including LGBT Health, Transgender Health, Population Health Management, and Breastfeeding Medicine. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc. 140 Huguenot Street, New Rochelle, NY 10801 http://www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax (914) 740-2101


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.